Moran, A., Ramakrishnan, S., Borg, C., Connolly, C., Couillard, S., Mwasuku, C., . . . Lehtimaki, L. (2020). Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma. European Respiratory Society.
Chicago Style (17th ed.) CitationMoran, A., S. Ramakrishnan, C. Borg, C. Connolly, S. Couillard, C. Mwasuku, I. Pavord, T. Hinks, and L. Lehtimaki. Depletion Rate of Blood Eosinophils with Mepolizumab, Benralizumab and Oral Prednisolone in Patients with Severe Asthma. European Respiratory Society, 2020.
ציטוט MLAMoran, A., et al. Depletion Rate of Blood Eosinophils with Mepolizumab, Benralizumab and Oral Prednisolone in Patients with Severe Asthma. European Respiratory Society, 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.